No headlines found.
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Tue, 11-Nov 5:00 PM ET)
embecta to Participate in Investor Events
Globe Newswire (Tue, 26-Aug 5:00 PM ET)
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Embecta Corp. trades on the NASDAQ stock market under the symbol EMBC.
As of November 13, 2025, EMBC stock price declined to $14.41 with 167,554 million shares trading.
EMBC has a beta of 1.13, meaning it tends to be more sensitive to market movements. EMBC has a correlation of 0.10 to the broad based SPY ETF.
EMBC has a market cap of $842.16 million. This is considered a Small Cap stock.
Last quarter Embecta Corp. reported $296 million in Revenue and $1.12 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.34.
In the last 3 years, EMBC traded as high as $36.64 and as low as $9.20.
The top ETF exchange traded funds that EMBC belongs to (by Net Assets): IJR, VTI, IWM, VB, VXF.
EMBC has underperformed the market in the last year with a return of -3.6%, while SPY returned +13.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EMBC shares. However, EMBC has outperformed the market in the last 3 month and 2 week periods, returning +9.3% and +6.0%, while SPY returned +4.7% and -2.4%, respectively. This indicates EMBC has been having a stronger performance recently.
EMBC support price is $14.14 and resistance is $14.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EMBC shares will trade within this expected range on the day.